Wells Fargo’s AstraZeneca AZN Stock Holding History

Wells Fargo’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-98,000	Closed	-$19.3M	–	7297
2026 Q1	$19.3M	Buy	+98,000	New	+$18.9M	﹤0.01%	1537
2025 Q2	–	Sell	-25,000	Closed	-$3.67M	–	7142
2025 Q1	$3.67M	Buy	+25,000	New	+$3.62M	﹤0.01%	2654
2022 Q1	–	Sell	-700	Closed	-$82K	–	7039
2021 Q4	$82K	Buy	+700	New	+$82.4K	﹤0.01%	5738
2021 Q2	–	Sell	-141,650	Closed	-$14.1M	–	6892
2021 Q1	$14.1M	Buy	141,650 +41,900	+42%	+$4.21M	﹤0.01%	1932
2020 Q4	$18K	Buy	99,750 +74,750	+299%	+$7.92M	﹤0.01%	5875
2020 Q3	$20K	Sell	25,000 -25,000	-50%	-$2.78M	﹤0.01%	5750
2020 Q2	$28K	Buy	+50,000	New	+$5.16M	﹤0.01%	5624
2019 Q1	–	Sell	-24,950	Closed	-$49K	–	6040
2018 Q4	$49K	Hold	24,950	–	–	﹤0.01%	5522
2018 Q3	$143K	Hold	24,950	–	–	﹤0.01%	5188
2018 Q2	$50K	Buy	+24,950	New	+$1.79M	﹤0.01%	5590
2017 Q3	–	Sell	-700	Closed	-$1K	–	6302
2017 Q2	$1K	Buy	+700	New	+$45.7K	﹤0.01%	6098
2017 Q1	–	Sell	-50,400	Closed	-$11K	–	6297
2016 Q4	$11K	Buy	+50,400	New	+$2.86M	﹤0.01%	5766
2015 Q1	–	Sell	-121,300	Closed	-$46K	–	6158
2014 Q4	$46K	Hold	121,300	–	–	﹤0.01%	5032
2014 Q3	$305K	Buy	121,300 +21,300	+21%	+$1.56M	﹤0.01%	4152
2014 Q2	$7.43M	Buy	+100,000	New	+$7.23M	﹤0.01%	2028

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo's AZN Position: Q2 2026 in Review

Wells Fargo increased its AstraZeneca (AZN) stake by 3.4% in Q2 2026, buying an estimated $9.74M and bringing the position to 1,596,427 shares worth $303M. The position accounts for 0.05% of the portfolio, ranked #316.

Wells Fargo first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $305M in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Wells Fargo held 1,596,427 shares of AstraZeneca worth $303M as of Q2 2026.
Wells Fargo bought 51,795 AstraZeneca shares in Q2 2026, an estimated $9.74M.
AstraZeneca made up 0.05% of Wells Fargo's portfolio in Q2 2026, its #316 holding.
Wells Fargo first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's AstraZeneca position peaked at $305M in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.